Invisible architects: traceless directing group strategy towards late-stage functionalization and synthesis of drug derivatives
Chemical Communications · 2026
DOI: 10.1039/d5cc06113j ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2026. Verfasst von Purushotam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Laboratory of Catalysis and Organic Synthesis, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India. d…. Hauptthemen laut MEDLINE: Pharmaceutical Preparations, Drug Design. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
Herein, we have demonstrated a comprehensive perspective and potential application of traceless directing group strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Laboratory of Catalysis and Organic Synthesis, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India. debasis.banerjee@cy.iitr.ac.in.
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Purushotam, Tarun, Haldar, S., Manubhai, S. M., & Banerjee, D. (2026). Invisible architects: traceless directing group strategy towards late-stage functionalization and synthesis of drug derivatives. Chemical Communications. https://doi.org/10.1039/d5cc06113j
Vancouver
Purushotam, Tarun, Haldar S, Manubhai SM, Banerjee D. Invisible architects: traceless directing group strategy towards late-stage functionalization and synthesis of drug derivatives. Chemical Communications. 2026. doi:10.1039/d5cc06113j
BibTeX
@article{Purushotam2026,
author = {Purushotam and Tarun and Haldar, Shuvojit and Manubhai, Sarvaiya Mayur and Banerjee, Debasis},
title = {Invisible architects: traceless directing group strategy towards late-stage functionalization and synthesis of drug derivatives},
journal = {Chemical Communications},
year = {2026},
doi = {10.1039/d5cc06113j}
}
EUVIMED